Works matching IS 14741776 AND DT 2002 AND VI 1 AND IP 9

Results: 20

HIV: Vif ? a new therapeutic target?

Published in:

Nature Reviews Drug Discovery, 2002, v. 1, n. 9, p. 658, doi. 10.1038/nrd899

By:

Bell, Elaine

Publication type:

Article

Opinion: Drug addictions: towards socially accepted and medically treatable diseases.

Published in:

Nature Reviews Drug Discovery, 2002, v. 1, n. 9, p. 731, doi. 10.1038/nrd896

By:

Pouletty, Philippe

Publication type:

Article

Protein tyrosine phosphatase 1B inhibitors for diabetes.

Published in:

Nature Reviews Drug Discovery, 2002, v. 1, n. 9, p. 696, doi. 10.1038/nrd895

By:

Johnson, Theodore O.;
Ermolieff, Jacques;
Jirousek, Michael R.

Publication type:

Article

Pharmacotherapy of addictions.

Published in:

Nature Reviews Drug Discovery, 2002, v. 1, n. 9, p. 710, doi. 10.1038/nrd897

By:

Kreek, Mary Jeanne;
LaForge, K. Steven;
Butelman, Eduardo

Publication type:

Article

From the analyst's couch: Erectile-dysfunction therapies.

Published in:

Nature Reviews Drug Discovery, 2002, v. 1, n. 9, p. 663, doi. 10.1038/nrd898

By:

Renaud, Ronald C.;
Xuereb, Hayley

Publication type:

Article

Clinical proteomics: translating benchside promise into bedside reality.

Published in:

Nature Reviews Drug Discovery, 2002, v. 1, n. 9, p. 683, doi. 10.1038/nrd891

By:

Petricoin, Emanuel F.;
Zoon, Kathryn C.;
Kohn, Elise C.;
Barrett, J. Carl;
Liotta, Lance A.

Publication type:

Article

Opinion: The druggable genome.

Published in:

Nature Reviews Drug Discovery, 2002, v. 1, n. 9, p. 727, doi. 10.1038/nrd892

By:

Hopkins, Andrew L.;
Groom, Colin R.

Publication type:

Article

Phosphodiesterase 5 inhibitors: current status and potential applications.

Published in:

Nature Reviews Drug Discovery, 2002, v. 1, n. 9, p. 674, doi. 10.1038/nrd893

By:

Rotella, David P.

Publication type:

Article

ATPases as drug targets: learning from their structure.

Published in:

Nature Reviews Drug Discovery, 2002, v. 1, n. 9, p. 665, doi. 10.1038/nrd894

By:

Chène, Patrick

Publication type:

Article

Drug delivery: Engineering a smoother ride.

Published in:

Nature Reviews Drug Discovery, 2002, v. 1, n. 9, p. 658, doi. 10.1038/nrd900

By:

Brazil, Melanie

Publication type:

Article

Anticancer drugs: Pulling the plug on cancer.

Published in:

Nature Reviews Drug Discovery, 2002, v. 1, n. 9, p. 657, doi. 10.1038/nrd901

By:

Kirkpatrick, Peter

Publication type:

Article

Obesity: Adipocyte metabolism.

Published in:

Nature Reviews Drug Discovery, 2002, v. 1, n. 9, p. 661, doi. 10.1038/nrd902

By:

Brazil, Melanie

Publication type:

Article

High-throughput screening: Lighting up targets with reporter ribozymes.

Published in:

Nature Reviews Drug Discovery, 2002, v. 1, n. 9, p. 659, doi. 10.1038/nrd903

By:

Kirkpatrick, Peter

Publication type:

Article

Target validation: Target for the modern-day ills?

Published in:

Nature Reviews Drug Discovery, 2002, v. 1, n. 9, p. 661, doi. 10.1038/nrd904

By:

Kirkpatrick, Peter

Publication type:

Article

Antipsychotics: How Goldilocks is partial to dopamine receptors.

Published in:

Nature Reviews Drug Discovery, 2002, v. 1, n. 9, p. 660, doi. 10.1038/nrd912

By:

Frantz, Simon

Publication type:

Article

Learning and memory: Weeding out memory extinction.

Published in:

Nature Reviews Drug Discovery, 2002, v. 1, n. 9, p. 662, doi. 10.1038/nrd906

By:

López, Juan Carlos

Publication type:

Article

Patent Watch.

Published in:: Nature Reviews Drug Discovery, 2002, v. 1, n. 9, p. 662
Publication type:: Article

Emerging unscathed?

Published in:

Nature Reviews Drug Discovery, 2002, v. 1, n. 9, p. 739, doi. 10.1038/nrd910

By:

Gershell, Leland J.;
Miller, Thomas A.

Publication type:

Article

The prince and the pauper.

Published in:: 2002
Publication type:: Editorial

In Brief.

Published in:: Nature Reviews Drug Discovery, 2002, v. 1, n. 9, p. 661, doi. 10.1038/nrd905
Publication type:: Article